RECRUITING

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.

Official Title

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome (TTTS)

Quick Facts

Study Start:2021-10-01
Study Completion:2031-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05008744

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Single placenta (Monochorionic)
  2. * Polyhydramnios present in recipient twin (Greater than 8 cm maximum vertical pocket below 20 weeks and greater than a 10 cm pocket for greater than 20 weeks gestational age)
  3. * Oligohydramnios present in donor twin (Less than 2 cm maximum vertical pocket)
  4. * Prominent bladder in the recipient/ non-filling bladder in the donor
  5. * Thin dividing membrane
  1. * Patients unwilling to participate in the study or to be followed up
  2. * Presence of major congenital anomalies incompatible with survival
  3. * Active pre-term labor Ruptured membranes
  4. * Chorioamnionitis
  5. * Vaginal bleeding

Contacts and Locations

Study Contact

Martin P Walker, MD
CONTACT
206-987-3539
martin.walker@seattlechildrens.org
Melissa Dorn, RN MN
CONTACT
206-987-4137
melissa.dorn@seattlechildrens.org

Principal Investigator

Martin P Walker, MD
PRINCIPAL_INVESTIGATOR
Seattle Childrens Hospital

Study Locations (Sites)

Seattle Childrens Hospital
Seattle, Washington, 98015
United States
University of Washington
Seattle, Washington, 98195
United States

Collaborators and Investigators

Sponsor: Seattle Children's Hospital

  • Martin P Walker, MD, PRINCIPAL_INVESTIGATOR, Seattle Childrens Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-01
Study Completion Date2031-10-01

Study Record Updates

Study Start Date2021-10-01
Study Completion Date2031-10-01

Terms related to this study

Keywords Provided by Researchers

  • Twin
  • Monochorionic
  • Fetoscopy
  • Laser

Additional Relevant MeSH Terms

  • Twin to Twin Transfusion as Antepartum Condition
  • Monochorionic Diamniotic Placenta